Roche (RHHVF) Stock Price, News & Analysis

Company Overview

Roche Holding AG is a Switzerland-based healthcare company that develops and supplies pharmaceutical products and diagnostic solutions. Its business is organized around two complementary divisions: Pharmaceuticals, which focuses on medicines, and Diagnostics, which provides tests, instruments and digital tools used in disease detection, monitoring and treatment decisions.

The company’s pharmaceutical portfolio includes therapies in areas such as oncology, immunology, neurology, ophthalmology and rare diseases. Roche also develops companion diagnostics and other personalized healthcare technologies intended to help identify patients who may benefit from particular treatments. Its diagnostics business serves hospitals, laboratories, healthcare professionals and patients with clinical laboratory, molecular, tissue-based and point-of-care testing products.

Founded in Basel, Switzerland, in 1896, Roche operates internationally and serves healthcare markets across numerous regions. The company is led by Chief Executive Officer Thomas Schinecker, who assumed the role in 2023, while Severin Schwan serves as chairman of the board.

Key Stats

• Today's Range: $415.07 to $442.60
• 50-Day Range: $414.98 to $468.60
• 52-Week Range: $318.81 to $490.33
• Volume: 74 shs
• Average Volume: 12,291 shs
• Market Capitalization: N/A
• P/E Ratio: 39.61
• Dividend Yield: 1.82%
• Price Target: N/A
• Consensus Rating: N/A

Roche Stock Analysis - MarketRank™

Roche scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Roche.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Roche is 39.61, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of Roche is 39.61, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.44.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Roche has a short interest ratio ("days to cover") of 91.56, which indicates bearish sentiment.

Change versus previous month

Short interest in Roche has recently increased by 29.81%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Roche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Roche does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Roche this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Roche insiders have not sold or bought any company stock.

Percentage Held by Institutions

29.01% of the stock of Roche is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:RHHVF
• CIK: N/A
• Web: www.roche.com
• Phone: (161) 688-1111
• Fax: N/A
• Employees: 103,249
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 39.61
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A